Gastric cancers are currently classified using clinicopathologic criteria, however existing classification systems are inadequate for guiding the treatment of individual patients. Understanding the genomic and epigenomic basis of gastric cancer may facilitate the molecular subtyping of gastric cancer patients and the development of novel drug treatments. Such information has already enhanced our understanding of gastric carcinogenesis, and may ultimately improve the medical management of gastric cancer patients in the future.
from Cancer via ola Kala on Inoreader http://ift.tt/1PVP9SL
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου